Finally, dysfunction of the p53 pathway—via MDM2 overexpression or TP53 mutation—impairs transcriptional induction of pro-apoptotic targets such as Bax and PUMA, substantially reducing tumor cell sensitivity to DNA-damaging agents (47–54). The gene discussed is TP53; the disease is neoplasm.